GlassScriptPhysician profile
Samineh Sehatbakhsh
NPI 1801281647
$37,798.56
in general payments reported to CMS, 2019-2025
15 companies · $3,533 in 2025
The $3,533 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,219 · 2020: $563 · 2021: $517 · 2022: $17K · 2023: $12K · 2024: $2,494 · 2025: $3,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Food and Beverage: $4,539 · Travel and Lodging: $2,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $11,250.00 |
| Food and Beverage | $4,538.62 |
| Travel and Lodging | $2,524.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,008.30 | 2021-2025 | Corevalve Evolut R, Ffrangio |
| Abbott Laboratories | $14,669.54 | 2020-2025 | Navitor, Mitraclip, Portico |
| Edwards Lifesciences Corporation | $2,146.06 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $1,104.41 | 2020-2025 | Watchman Flx, General - Therapies, Farapulse |
| Penumbra, INC. | $1,050.19 | 2022 | |
| Medtronic Vascular, INC. | $765.43 | 2019-2020 | |
| Teleflex LLC | $268.90 | 2024 | Manta |
| Astellas Pharma US INC | $224.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $132.23 | 2019-2020 | |
| Cardiovascular Systems INC. | $118.91 | 2021 | |
| Akcea Therapeutics, INC. | $107.74 | 2020 | |
| Novartis Pharmaceuticals Corporation | $92.80 | 2019 | |
| Cardinal Health 200 LLC | $48.04 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.02 | 2021-2025 | Lifevest |
| Biosense Webster, INC. | $24.99 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samineh Sehatbakhsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.